Tetanus
📧 Sign up to get email alerts when something new happens for Tetanus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults [Phase 1, Phase 2]
A Phase 1/2 clinical trial entry evaluating the safety and immunogenicity of GC3111B in healthy adults, with recruitment ongoing.
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series [Phase 2, Phase 3]
Phase II/III trial update evaluating the immunogenicity, safety, and lot-to-lot consistency of LBVD, a fully liquid hexavalent DTaP-HepB-IPV…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Safety and Immunogenicity Study of Tdap Vaccinations for Plasma Donors [Phase 2]
This Phase 2 clinical trial evaluated the safety and immunogenicity of Tdap vaccination in plasma donors. The study has completed.
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma) [Phase 3]
Phase 3 trial evaluating a pentavalent DTP-HB-Hib vaccine for immunogenicity and safety has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Immune Response followingTdap Vaccine in Pregnancy
This clinical trial update reports on the immune response following administration of the Tdap vaccine during pregnancy. The study, sponsore…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/Phase 2 study assessing safety, tolerability, and pharmacokinetics/pharmacodynamics of SNA02-…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Study of Concomitant Administration of the sIPV and DTaP or MMR [Phase 4]
Phase 4 trial evaluating concomitant administration of Sabin inactivated polio vaccine (sIPV) with DTaP or MMR vaccines; sponsored by the In…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above) [Phase 1]
This document provides a status update on a Phase 1 clinical trial of an adsorbed cell-free five-component DPT vaccine for people aged 6 yea…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine [Phase 4]
Phase 4 trial update evaluating a live attenuated varicella vaccine co-administered with MMR or DTaP vaccines; study status is NOT_YET_RECRU…
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component) [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial of an adsorbed cell-free five-component DPT vaccine conducted by CanSino Biologics Inc. is currently active…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP) [Phase 3]
Phase 3 clinical trial update for a diphtheria, tetanus and acellular pertussis vaccine adsorbed (DTcP) developed by CanSino Biologics; the …
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Confirmatory Study of BK1310 in Healthy Infants [Phase 3]
A Phase 3 confirmatory trial of BK1310 in healthy infants evaluating protection against tetanus, diphtheria, pertussis, poliomyelitis, and b…
-
CLINICAL_TRIALS trial_result · 2024-12-02Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over [Phase 3]
Phase 3 clinical trial evaluating the safety and immunogenicity of a single-dose adsorbed tetanus vaccine in adults has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over [Phase 1]
Phase 1 study evaluating the safety and immunogenicity of a single-dose adsorbed tetanus vaccine in adults 18 years and older; the trial has…
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants [Phase 1, Phase 2]
Clinical trial update on a Phase 1/2 safety and immunogenicity study of a pentavalent DTwP-HepB-Hib-IPV vaccine in Indonesian infants; the t…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants [Phase 2]
Phase 2 trial evaluating safety and immunogenicity of a pneumococcal conjugate vaccine when administered concomitantly with routine pediatri…
-
CLINICAL_TRIALS research · 2024-10-10Clinical Trial Update: A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 Injection [Phase 3]
A Phase 3 clinical trial evaluating GR2001 Injection for tetanus is currently recruiting, with planned assessments of efficacy, safety, phar…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age [Phase 2]
Phase 2 trial to evaluate the immunogenicity of LR20062 versus control in healthy infants at 2, 4, and 6 months of age. The study targets pr…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: A Randomized, Open-Label, Parallel-Design Pharmacokinetic and Pharmacodynamic Interaction Study of TNM002 and Adsorbed Tetanus Vaccine [Phase 1]
Phase 1 randomized PK/PD interaction study evaluating potential interactions between TNM002 and Adsorbed Tetanus Vaccine has completed.
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants [NA]
This clinical trial is evaluating the safety and immunogenicity of a pentavalent DTaP-IPV/Hib vaccine in 2-month-old Chinese infants; the st…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV [Phase 3]
This document reports a Phase 3 clinical trial evaluating the immunogenicity and safety of a hexavalent vaccine that contains a reduced-dose…
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: Safety and Immunogenicity of Tetanus Vaccine, Adsorbed in 18~44 Years Old Population [Phase 3]
A Phase 3 clinical trial evaluating the safety and immunogenicity of a tetanus toxoid adsorbed vaccine in adults aged 18-44 has completed.
-
CLINICAL_TRIALS research · 2024-05-28Clinical Trial Update: Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant Women [Phase 4]
A Phase 4 clinical trial update on pertussis vaccination in HIV-infected and HIV-uninfected pregnant women using the DTaP vaccine. The study…
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants [Phase 3]
Phase 3 trial update evaluating immunogenicity and safety of a diphtheria, tetanus, and pertussis vaccine in 3-month-old infants; currently …
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: Study to Compare the Efficacy and Safety of Passive Immunization With TNM002 Injection and Human Tetanus Immunoglobulin as Prophylaxis Against Tetanus [Phase 3]
Phase 3 trial comparing passive immunization with TNM002 Injection to human tetanus immunoglobulin for tetanus prophylaxis has completed.